Clinical trial
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic…
NCT00447876 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00447876 |
|---|---|
| Title | Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis |
| Official title | Double-blind, Placebo-controlled, Randomised, Multicentre Study on the Efficacy and Safety of a Single Injection of Botulinum Toxin A (200 Units Dysport®) in the Treatment of Chronic Plantar Fasciitis |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Plantar Fasciitis |
| Intervention type | Biological, Drug |
| Interventions | Botulinum toxin type A, Placebo |
| Enrollment | 40 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Mar 15, 2007 |
| Last update posted | Nov 22, 2019 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: